Institutional investors purchased a net $3.0 million shares of BTX during the quarter ended March 2016. This may signal that the smart money is gaining interest in this company as the 45.60% of shares outstanding that institutional investors hold is actually below the Medical Specialties industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BROADWOOD CAPITAL, INC. Bought 2.7 Million shares of BioTime Inc
GREENWAY PARTNERS LP Bought 237.7 Thousand shares of BioTime Inc